[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20026193L - Polymorfe former/hydrater av N-[4-(3-klor-4-fluorfenylamino)- 7-(3-morfolin-4-ylpropoksy)-kinazolin-6-yl]-akrylamid-dihydroklorid - Google Patents

Polymorfe former/hydrater av N-[4-(3-klor-4-fluorfenylamino)- 7-(3-morfolin-4-ylpropoksy)-kinazolin-6-yl]-akrylamid-dihydroklorid

Info

Publication number
NO20026193L
NO20026193L NO20026193A NO20026193A NO20026193L NO 20026193 L NO20026193 L NO 20026193L NO 20026193 A NO20026193 A NO 20026193A NO 20026193 A NO20026193 A NO 20026193A NO 20026193 L NO20026193 L NO 20026193L
Authority
NO
Norway
Prior art keywords
ylpropoxy
fluorophenylamino
quinazolin
morpholin
hydrates
Prior art date
Application number
NO20026193A
Other languages
English (en)
Norwegian (no)
Other versions
NO20026193D0 (no
Inventor
Hubert Barth
Klaus Steiner
Simon Schneider
Dietmar Huels
Andreas Muehlenfeld
Manfred Westermayer
Original Assignee
Goedecke Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Gmbh filed Critical Goedecke Gmbh
Publication of NO20026193D0 publication Critical patent/NO20026193D0/no
Publication of NO20026193L publication Critical patent/NO20026193L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20026193A 2000-06-30 2002-12-23 Polymorfe former/hydrater av N-[4-(3-klor-4-fluorfenylamino)- 7-(3-morfolin-4-ylpropoksy)-kinazolin-6-yl]-akrylamid-dihydroklorid NO20026193L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031971A DE10031971A1 (de) 2000-06-30 2000-06-30 Polymorphe Formen/Hydrate von N-[4-(3-Chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-chinazolin-6-yl]-acrylamid Dihydrochlorid, Verfahren zu ihrer Herstellung sowie die Verwendung derselben zur Herstellung von Medikamenten mit irreversibler Tyrosinkinasehemmwirkung
PCT/EP2001/006733 WO2002000630A1 (en) 2000-06-30 2001-06-15 Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride

Publications (2)

Publication Number Publication Date
NO20026193D0 NO20026193D0 (no) 2002-12-23
NO20026193L true NO20026193L (no) 2003-01-27

Family

ID=7647397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026193A NO20026193L (no) 2000-06-30 2002-12-23 Polymorfe former/hydrater av N-[4-(3-klor-4-fluorfenylamino)- 7-(3-morfolin-4-ylpropoksy)-kinazolin-6-yl]-akrylamid-dihydroklorid

Country Status (39)

Country Link
US (1) US20040034022A1 (es)
EP (1) EP1299363A1 (es)
JP (1) JP2004501902A (es)
KR (1) KR20030014403A (es)
CN (1) CN1438994A (es)
AP (1) AP2002002694A0 (es)
AR (1) AR031854A1 (es)
AU (1) AU2001283861A1 (es)
BG (1) BG107352A (es)
BR (1) BR0112082A (es)
CA (1) CA2412535A1 (es)
CZ (1) CZ20024037A3 (es)
DE (1) DE10031971A1 (es)
DZ (1) DZ3342A1 (es)
EA (1) EA005294B1 (es)
EC (1) ECSP024413A (es)
EE (1) EE200200714A (es)
GT (1) GT200100124A (es)
HN (1) HN2001000134A (es)
HR (1) HRP20021019A2 (es)
HU (1) HUP0300900A3 (es)
IL (1) IL152419A0 (es)
IS (1) IS6596A (es)
MA (1) MA26924A1 (es)
MX (1) MXPA03000101A (es)
NO (1) NO20026193L (es)
NZ (1) NZ522001A (es)
OA (1) OA12301A (es)
PA (1) PA8520801A1 (es)
PE (1) PE20020116A1 (es)
PL (1) PL365127A1 (es)
SK (1) SK17642002A3 (es)
SV (1) SV2002000517A (es)
TN (1) TNSN01090A1 (es)
UA (1) UA73588C2 (es)
UY (1) UY26803A1 (es)
WO (1) WO2002000630A1 (es)
YU (1) YU99802A (es)
ZA (1) ZA200209717B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100885835B1 (ko) 2004-05-06 2009-02-26 워너-램버트 캄파니 엘엘씨 4-페닐아미노-퀴나졸린-6-일-아미드
DE102006000122A1 (de) * 2006-03-17 2007-09-20 Aug. Winkhaus Gmbh & Co. Kg Schlüssel für einen Schließzylinder und Schließzylinder für einen solchen Schlüssel
JP6717947B2 (ja) * 2015-12-25 2020-07-08 シュアンチュー ファーマ カンパニー，リミティド キナゾリン誘導体の結晶及びその調製方法
CN108430990B (zh) * 2015-12-25 2020-08-25 山东轩竹医药科技有限公司 喹唑啉衍生物的晶体及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295468B6 (cs) * 1996-04-12 2005-08-17 Warner-Lambert Company Polycyklické sloučeniny
DK1131304T3 (da) * 1998-11-19 2003-03-24 Warner Lambert Co N-[4-(3-chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamid, en irreversibel inhibitor for tyrosin-kinaser

Also Published As

Publication number Publication date
PE20020116A1 (es) 2002-02-27
BG107352A (bg) 2003-07-31
EE200200714A (et) 2004-08-16
KR20030014403A (ko) 2003-02-17
HN2001000134A (es) 2001-09-11
UY26803A1 (es) 2002-01-31
MA26924A1 (fr) 2004-12-20
ECSP024413A (es) 2003-03-31
IL152419A0 (en) 2003-05-29
MXPA03000101A (es) 2004-09-13
SV2002000517A (es) 2002-07-03
UA73588C2 (en) 2005-08-15
AP2002002694A0 (en) 2002-12-31
YU99802A (sh) 2005-11-28
WO2002000630A1 (en) 2002-01-03
ZA200209717B (en) 2003-12-01
DE10031971A1 (de) 2002-01-10
EP1299363A1 (en) 2003-04-09
OA12301A (en) 2003-11-10
IS6596A (is) 2002-10-28
HRP20021019A2 (en) 2004-02-29
CA2412535A1 (en) 2002-01-03
PL365127A1 (en) 2004-12-27
EA005294B1 (ru) 2004-12-30
EA200300094A1 (ru) 2003-04-24
NZ522001A (en) 2004-07-30
DZ3342A1 (fr) 2002-01-03
HUP0300900A3 (en) 2004-01-28
CZ20024037A3 (cs) 2004-01-14
BR0112082A (pt) 2003-05-06
GT200100124A (es) 2002-06-27
US20040034022A1 (en) 2004-02-19
PA8520801A1 (es) 2003-06-30
NO20026193D0 (no) 2002-12-23
HUP0300900A2 (hu) 2003-10-28
JP2004501902A (ja) 2004-01-22
SK17642002A3 (sk) 2004-05-04
TNSN01090A1 (fr) 2005-11-10
CN1438994A (zh) 2003-08-27
AU2001283861A1 (en) 2002-01-08
AR031854A1 (es) 2003-10-08

Similar Documents

Publication Publication Date Title
EE200100271A (et) N-[4-(3-kloro-4-fluorofenüülamino)-7-(3-morfoliin-4-üülpropoksü)kinasoliin-6-üül]ak rüülamiid kui türosiinkinaaside pöördumatu inhibiitor
DE60324805D1 (de) Inhibitoren von tyrosinkinasen
ATE557008T1 (de) 4- ( n-phenylamino ) -chinazoline/chinoline als tyrosinkinaseinhibitoren
HU229601B1 (en) Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
ATE309996T1 (de) Chinolinonderivate als tyrosin-kinase inhibitoren
NO20026282L (no) Inhibitorer av kobberholdige aminoksydaser
EE200300470A (et) Aldoosreduktaasi püridasinooninhibiitorid
ATE269701T1 (de) Gyrase-inhibitoren und ihre verwendung
NO20042080L (no) Inhibitorer for post-prolin spaltningsproteaser
DE60208661D1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
ATE325795T1 (de) Rho-kinase inhibitoren
ATE353889T1 (de) Rho-kinase inhibitoren
NO20021910D0 (no) Stabil polymorf av N-(3-etynylfenylamino)-6,7-bis(2- metoksyetoksy)-4-quinazolinamin hydroklorid, fremgangsmåte forfremstilling og farmasöytisk anvendelse
ATE370123T1 (de) 3-cyanochinoline als inhibitoren von egf-r- und her2-kinasen
DE60309342D1 (de) Benzimidazole und benzothiazole als inhibitoren der map-kinase
DE60021423D1 (de) 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren
DE60220522D1 (de) Kombination von einem aldosterone rezeptor antagonisten und einem hmg coa reduktase hemmer
NO20026193D0 (no) Polymorfe former/hydrater av N-[4-(3-klor-4-fluorfenylamino)- 7-(3-morfolin-4-ylpropoksy)-kinazolin-6-yl]-akrylamid-dihydroklorid
NO20041968L (no) Anvendelse av cystationin
NO20035605D0 (no) Pediatrisk formulering av gatifloxacin
DE60330323D1 (de) Stereoselektive alkylierung von chirale 2-methyl-4-geschützte piperazinen
NO20031698D0 (no) Krystallformer av 1-(6-klor-5-(trifluormetyl)-2- pyridinyl)piperazin-hydroklorid
NO20033163D0 (no) Ny anvendelse av iloperidon
AU2002251636A1 (en) Novel use of tyrosine kinase inhibitor
FI20002015A0 (fi) Kuparia sisältävien amiinioksidaasien inhibiittorit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application